SMS Pharmaceuticals has received temporary revocation from Andhra Pradesh Pollution Control Board (APPCB) with immediate effect. The company has received revocation for its Unit -1 located at Kazipalli industrial area Medak District, Andhra Pradesh, satisfied with the environmental management measures taken by it in the company's Unit-I and the unit has commenced operations.
Earlier with reference to announcement dated June 23, 2011, SMS Pharmaceuticals had received a closure order from Andhra Pradesh Pollution Control Board for its Unit -1 located at Kazipalli industrial area Medak District, Andhra Pradesh for non compliance of certain conditions. Most of the conditions were already complied and the same was being communicated to APPCB immediately.
SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. It is focused on API manufacturing and is the single largest producer of anti ulcer products and is renowned among the clientele for the excellent quality of product and customer service.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1619.95 |
| Dr. Reddys Lab | 1315.85 |
| Cipla | 1294.75 |
| Zydus Lifesciences | 927.15 |
| Lupin | 2296.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: